Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yunzhi Essence to Improve Quality of Life in Advanced Cancer
NCT05754801Phase 2Recruiting
- Sponsor
- The Chinese University of Hong Kong
- Start
- Jan 2024
- Primary completion
- Mar 2027
- Modality
- NHE (Natural Herbal Extract)
- Countries
- 1
01
Overview
A Phase 2 trial of Oncozac in cancer, sponsored by The Chinese University of Hong Kong. Started Jan 2024; status: recruiting.
02
Drugs
Oncozac
03
Conditions
cancer
Beyond the preview
Go deeper on NCT05754801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05754801.